GlobeNewswire - Industry News on Health Care http://www.10gbhost.com/RssFeed/industry/4000-Health%20Care/feedTitle/GlobeNewswire%20-%20Industry%20News%20on%20Health%20Care Contains the last 20 releases newsdesk@globenewswire.com (NewsDesk) Thu, 04 Feb 2021 21:30:00 GMT webmaster@globenewswire.com (Webmaster) http://www.10gbhost.com/news-release/2021/02/04/2170353/0/en/Sarepta-Therapeutics-Announces-Winners-of-the-Rare-Lessons-Lesson-Planning-Competition.html http://www.10gbhost.com/news-release/2021/02/04/2170353/0/en/Sarepta-Therapeutics-Announces-Winners-of-the-Rare-Lessons-Lesson-Planning-Competition.html Nasdaq:SRPT US8036071004 Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.?(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition. Sarepta has granted the winning authors $2,500 each and $2,500 to the educational institution with which each is affiliated. The winning submissions are now available on sharemylesson.com, and more information about the authors can be found at Sarepta.com/rarelessons.

]]>
Thu, 04 Feb 2021 21:30 GMT 2170353 en GlobeNewswire Inc. Sarepta Therapeutics, Inc. Thu, 04 Feb 2021 21:30 GMT Health
http://www.10gbhost.com/news-release/2021/02/04/2170352/0/en/Evaxion-Biotech-Announces-Pricing-of-Initial-Public-Offering.html http://www.10gbhost.com/news-release/2021/02/04/2170352/0/en/Evaxion-Biotech-Announces-Pricing-of-Initial-Public-Offering.html Evaxion Biotech Announces Pricing of Initial Public Offering COPENHAGEN, Denmark, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (“Evaxion”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, today announced the pricing of its initial public offering of 3,000,000 American Depositary Shares (“ADSs”), at a public offering price of $10 per ADS, with each such ADS representing one ordinary share, DKK 1 nominal value per share, of Evaxion (“Ordinary Shares”). The gross proceeds from the offering are expected to be approximately $30 million before deducting underwriting fees and commissions and other offering expenses. Evaxion has granted the underwriters an option for a period of 30 days from the date of the final prospectus to purchase an additional 450,000 ADSs at the initial public offering price.

]]>
Thu, 04 Feb 2021 21:16 GMT 2170352 en GlobeNewswire Inc. Evaxion Biotech Thu, 04 Feb 2021 21:17 GMT Health Initial Public Offerings Stock Market News
http://www.10gbhost.com/news-release/2021/02/04/2170346/0/en/CooperCompanies-Announces-Release-Date-for-First-Quarter-2021.html http://www.10gbhost.com/news-release/2021/02/04/2170346/0/en/CooperCompanies-Announces-Release-Date-for-First-Quarter-2021.html NYSE:COO US2166484020 CooperCompanies Announces Release Date for First Quarter 2021 SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.?? Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

]]>
Thu, 04 Feb 2021 21:15 GMT 2170346 en GlobeNewswire Inc. The Cooper Companies, Inc. Thu, 04 Feb 2021 21:15 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/04/2170312/0/en/Zealand-Pharma-to-Host-R-D-Day-on-March-5-2021.html http://www.10gbhost.com/news-release/2021/02/04/2170312/0/en/Zealand-Pharma-to-Host-R-D-Day-on-March-5-2021.html Copenhagen:ZEAL Nasdaq:ZEAL DK0060257814 US98920Y3045 7714 Zealand Pharma to Host R&D Day on March 5, 2021

]]>
Thu, 04 Feb 2021 21:05 GMT 2170312 en GlobeNewswire Inc. Zealand Pharma Thu, 04 Feb 2021 21:05 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/04/2170314/0/en/Relay-Therapeutics-to-Participate-in-Fireside-Chat-at-Guggenheim-Healthcare-Talks-2021-Oncology-Day.html http://www.10gbhost.com/news-release/2021/02/04/2170314/0/en/Relay-Therapeutics-to-Participate-in-Fireside-Chat-at-Guggenheim-Healthcare-Talks-2021-Oncology-Day.html Nasdaq:RLAY US75943R1023 Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on Thursday, February 11, 2021 at 3:30 p.m. ET. The fireside chat will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. Within 24 hours following the fireside chat, an archived replay of the webcast will be available for up to one year.

]]>
Thu, 04 Feb 2021 21:05 GMT 2170314 en GlobeNewswire Inc. Relay Therapeutics, Inc. Thu, 04 Feb 2021 21:05 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/04/2170318/0/en/Genocea-to-Host-Fourth-Quarter-2020-Corporate-Update-Conference-Call-Webcast.html http://www.10gbhost.com/news-release/2021/02/04/2170318/0/en/Genocea-to-Host-Fourth-Quarter-2020-Corporate-Update-Conference-Call-Webcast.html Nasdaq:GNCA US3724271040 Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its fourth quarter 2020 financial results and corporate update conference call and live audio webcast on?Thursday, February 11th?at 8:30 a.m. ET.

]]>
Thu, 04 Feb 2021 21:05 GMT 2170318 en GlobeNewswire Inc. Genocea Biosciences, Inc. Thu, 04 Feb 2021 21:05 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/04/2170324/0/en/Prothena-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Host-Webcast-Conference-Call-on-February-11th.html http://www.10gbhost.com/news-release/2021/02/04/2170324/0/en/Prothena-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results-and-Host-Webcast-Conference-Call-on-February-11th.html Nasdaq:PRTA IE00B91XRN20 Prothena to Report Fourth Quarter and Full Year 2020 Financial Results and Host Webcast Conference Call on February 11th DUBLIN, Ireland, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, announced today that it will report its fourth quarter and full year 2020 financial results on Thursday, February 11, 2021 before the open of the U.S. financial markets. The announcement will be followed by a live audio conference call at 8:30 AM ET.

]]>
Thu, 04 Feb 2021 21:05 GMT 2170324 en GlobeNewswire Inc. Prothena Corporation plc Thu, 04 Feb 2021 21:05 GMT Calendar of Events
http://www.10gbhost.com/news-release/2021/02/04/2170327/0/en/T2-Biosystems-T2SARS-CoV-2-Panel-Proves-Capable-of-Detecting-the-Brazil-P-1-Variant-of-the-SARS-CoV-2-Virus.html http://www.10gbhost.com/news-release/2021/02/04/2170327/0/en/T2-Biosystems-T2SARS-CoV-2-Panel-Proves-Capable-of-Detecting-the-Brazil-P-1-Variant-of-the-SARS-CoV-2-Virus.html Nasdaq:TTOO US89853L1044 T2 Biosystems T2SARS-CoV-2? Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis

]]>
Thu, 04 Feb 2021 21:05 GMT 2170327 en GlobeNewswire Inc. T2 Biosystems, Inc. Thu, 04 Feb 2021 21:05 GMT Health Product / Services Announcement
http://www.10gbhost.com/news-release/2021/02/04/2170335/0/en/Novavax-Announces-Start-of-Rolling-Review-by-Multiple-Regulatory-Authorities-for-COVID-19-Vaccine-Authorization.html http://www.10gbhost.com/news-release/2021/02/04/2170335/0/en/Novavax-Announces-Start-of-Rolling-Review-by-Multiple-Regulatory-Authorities-for-COVID-19-Vaccine-Authorization.html Nasdaq:NVAX US6700021040 Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its pivotal Phase 3 trials in the United Kingdom (U.K.) and United States (U.S.) and through initial authorization for emergency use granted under country-specific regulations.

]]>
Thu, 04 Feb 2021 21:05 GMT 2170335 en GlobeNewswire Inc. Novavax, Inc. Thu, 04 Feb 2021 21:10 GMT Health covid vaccine regulatory authorization
http://www.10gbhost.com/news-release/2021/02/04/2170309/0/en/Berkeley-Lights-Announces-CFO-Transition-and-C-Level-Additions.html http://www.10gbhost.com/news-release/2021/02/04/2170309/0/en/Berkeley-Lights-Announces-CFO-Transition-and-C-Level-Additions.html Nasdaq:BLI US0843101017 Berkeley Lights Announces CFO Transition and C-Level Additions Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights

]]>
Thu, 04 Feb 2021 21:02 GMT 2170309 en GlobeNewswire Inc. Berkeley Lights, Inc Thu, 04 Feb 2021 21:02 GMT Calendar of Events Directors and Officers Health
http://www.10gbhost.com/news-release/2021/02/04/2170310/0/en/Fluidigm-to-Participate-in-BTIG-Virtual-MedTech-Digital-Health-Life-Science-and-Diagnostic-Tools-Conference.html http://www.10gbhost.com/news-release/2021/02/04/2170310/0/en/Fluidigm-to-Participate-in-BTIG-Virtual-MedTech-Digital-Health-Life-Science-and-Diagnostic-Tools-Conference.html Nasdaq:FLDM US34385P1084 Fluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference SOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation?(Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the company’s management will participate in investor meetings at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021.

]]>
Thu, 04 Feb 2021 21:02 GMT 2170310 en GlobeNewswire Inc. Fluidigm Corporation Thu, 04 Feb 2021 21:02 GMT Calendar of Events Biomarker cancer clinical trial COVID-19 Diagnostic genomics healthcare Infectious disease mass cytometry microfluidic PCR Pharma
http://www.10gbhost.com/news-release/2021/02/04/2170297/0/en/Misonix-Reports-Fiscal-2021-Second-Quarter-Financial-Results.html http://www.10gbhost.com/news-release/2021/02/04/2170297/0/en/Misonix-Reports-Fiscal-2021-Second-Quarter-Financial-Results.html Nasdaq:MSON US6048711039 Misonix Reports Fiscal 2021 Second Quarter Financial Results FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021 second quarter ended December 31, 2020 as summarized below:

]]>
Thu, 04 Feb 2021 21:01 GMT 2170297 en GlobeNewswire Inc. MISONIX, Inc. Thu, 04 Feb 2021 21:01 GMT Calendar of Events Earnings Releases and Operating Results Health Misonix Fiscal 2021 second quarter earnings ultrasonic Medical Devices regenerative products wound surgical Healthcare
http://www.10gbhost.com/news-release/2021/02/04/2170302/0/en/Sientra-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2020-Results.html http://www.10gbhost.com/news-release/2021/02/04/2170302/0/en/Sientra-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2020-Results.html Nasdaq:SIEN US82621J1051 Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth

]]>
Thu, 04 Feb 2021 21:01 GMT 2170302 en GlobeNewswire Inc. Sientra, Inc. Thu, 04 Feb 2021 21:01 GMT Pre-Release Comments
http://www.10gbhost.com/news-release/2021/02/04/2170303/0/en/Acutus-Medical-to-Present-at-the-BTIG-Virtual-MedTech-Digital-Health-Life-Science-and-Diagnostic-Tools-Conference.html http://www.10gbhost.com/news-release/2021/02/04/2170303/0/en/Acutus-Medical-to-Present-at-the-BTIG-Virtual-MedTech-Digital-Health-Life-Science-and-Diagnostic-Tools-Conference.html Nasdaq:AFIB US0051111096 Acutus Medical to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference CARLSBAD, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Thursday, February 18, 2021 at 2:00 p.m. Eastern Time.

]]>
Thu, 04 Feb 2021 21:01 GMT 2170303 en GlobeNewswire Inc. Acutus Medical, Inc. Thu, 04 Feb 2021 21:01 GMT Calendar of Events Health
http://www.10gbhost.com/news-release/2021/02/04/2170304/0/en/Itamar-Medical-Announces-Proposed-Offering-of-American-Depositary-Shares.html http://www.10gbhost.com/news-release/2021/02/04/2170304/0/en/Itamar-Medical-Announces-Proposed-Offering-of-American-Depositary-Shares.html Nasdaq:ITMR TASE:ITMR.TA US4654371016 IL0011024580 Itamar Medical Announces Proposed Offering of American Depositary Shares CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (“ADSs”) of the Company. Each ADS represents 30 ordinary shares of the Company. The ADSs to be sold in the offering will be offered by the Company and one of its shareholders, Viola Growth 2 A.V. Limited Partnership (the “Selling Shareholder”). The Company and the Selling Shareholder intend to grant to the underwriters a 30-day option to purchase up to an additional 15% of the ADSs being offered on the same terms and conditions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

]]>
Thu, 04 Feb 2021 21:01 GMT 2170304 en GlobeNewswire Inc. Itamar Medical Ltd. Thu, 04 Feb 2021 21:01 GMT Changes in company's own shares Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/02/04/2170271/0/fr/IBA-ACQUISITION-D-ACTIONS-PROPRES.html http://www.10gbhost.com/news-release/2021/02/04/2170271/0/fr/IBA-ACQUISITION-D-ACTIONS-PROPRES.html Brussels:IBAB BE0003766806 IBA – ACQUISITION D’ACTIONS PROPRES Publication immédiate – 4 février 2021

]]>
Thu, 04 Feb 2021 19:45 GMT 2170271 fr GlobeNewswire Inc. IBA SA Thu, 04 Feb 2021 19:45 GMT Tab FR


]]>
GlobeNewswire Inc.
Law & Legal Issues European Regulatory News corporate
http://www.10gbhost.com/news-release/2021/02/04/2170271/0/en/Iba-Acquisition-of-Own-Shares.html http://www.10gbhost.com/news-release/2021/02/04/2170271/0/en/Iba-Acquisition-of-Own-Shares.html Brussels:IBAB BE0003766806 Iba – Acquisition of Own Shares ??

]]>
Thu, 04 Feb 2021 19:45 GMT 2170271 en GlobeNewswire Inc. IBA SA Thu, 04 Feb 2021 19:45 GMT Tab EN


]]>
GlobeNewswire Inc.
Law & Legal Issues European Regulatory News corporate
http://www.10gbhost.com/news-release/2021/02/04/2170264/0/en/Access-Power-Co-Inc-is-pleased-to-announce-that-the-Company-has-completed-all-the-required-documentation-with-OTC-Markets-for-a-venue-change-consideration-into-the-Pink-Current-Inf.html http://www.10gbhost.com/news-release/2021/02/04/2170264/0/en/Access-Power-Co-Inc-is-pleased-to-announce-that-the-Company-has-completed-all-the-required-documentation-with-OTC-Markets-for-a-venue-change-consideration-into-the-Pink-Current-Inf.html OTC Markets:ACCR US00431N1081 Access-Power & Co., Inc. is pleased to announce that the Company has completed all the required documentation with OTC Markets for a venue change consideration into the Pink Current Information tier GRAND HAVEN, Mich., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Access-Power & Co., Inc., (“ACCR or the Company”), a Grand Haven based diversified holding Company is pleased to announce that it has completed all of?the required documentation with OTC Markets for a venue change consideration into the Pink Current Information tier.?Patrick J Jensen, our sole Director stated, “We must be clear with our Shareholders and Market Makers…this re-application process can take about 4 weeks or longer.”? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ??

]]>
Thu, 04 Feb 2021 19:25 GMT 2170264 en GlobeNewswire Inc. Access-Power, Inc. Thu, 04 Feb 2021 19:26 GMT Stock Market News merger deal medical marijuana
http://www.10gbhost.com/news-release/2021/02/04/2170248/0/en/MultiBrush-by-Rendever-Now-Available-on-SideQuest-Providing-Artists-with-a-Collaborative-Tool-in-Virtual-Reality.html http://www.10gbhost.com/news-release/2021/02/04/2170248/0/en/MultiBrush-by-Rendever-Now-Available-on-SideQuest-Providing-Artists-with-a-Collaborative-Tool-in-Virtual-Reality.html MultiBrush by Rendever Now Available on SideQuest, Providing Artists with a Collaborative Tool in Virtual Reality Rendever’s CTO, Tom Neumann, was the first to develop a working multiplayer form of Tilt Brush, all in an effort to connect community members together]]> Thu, 04 Feb 2021 18:30 GMT 2170248 en GlobeNewswire Inc. Rendever Thu, 04 Feb 2021 18:30 GMT Product / Services Announcement Tilt Brush SideQuest Oculus Quest MultiBrush by Rendever VR for Seniors http://www.10gbhost.com/news-release/2021/02/04/2170238/0/en/PRA-Health-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2020-Earnings.html http://www.10gbhost.com/news-release/2021/02/04/2170238/0/en/PRA-Health-Sciences-to-Report-Fourth-Quarter-and-Full-Year-2020-Earnings.html Nasdaq:PRAH US69354M1080 PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings RALEIGH, N.C., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:?PRAH) will release its fourth quarter and full year 2020 results after the market closes on Thursday, February 25, 2021. The Company will also host a conference call on Friday, February 26, 2021 at 9:00 a.m. (ET) to discuss the results with members of the investment community.

]]>
Thu, 04 Feb 2021 18:01 GMT 2170238 en GlobeNewswire Inc. PRA Health Sciences, Inc. Thu, 04 Feb 2021 18:01 GMT Calendar of Events PHARMACEUTICALS BIOTECHNOLOGY EARNINGS Contract Research Organization
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看